841 BC556, A POTENT, PAN-GENOTYPIC, HIGH BARRIER TO RESISTANCE, SECOND GENERATION CYCLOPHILIN INHIBITOR FOR TREATMENT OF CHRONIC HCV INFECTION

Steven J. Moss, Matthew A. Gregory, P. Leyssen et al.|Journal of Hepatology|2012

Cited by 2